Atlas Trials

Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia

Clinical trial NCT04535063 · COMPLETED

Trial details

NCT number
NCT04535063
Sponsor
Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Covid19 Pneumonia
Start date
2020-04-18
Primary completion
2020-12-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.